Logo image of SRT.DE

SARTORIUS AG (SRT.DE) Stock Fundamental Analysis

Europe - Frankfurt Stock Exchange - FRA:SRT - DE0007165607 - Common Stock

194.8 EUR
+3.6 (+1.88%)
Last: 11/28/2025, 7:00:00 PM
Fundamental Rating

3

Taking everything into account, SRT scores 3 out of 10 in our fundamental rating. SRT was compared to 19 industry peers in the Life Sciences Tools & Services industry. SRT may be in some trouble as it scores bad on both profitability and health. SRT is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

In the past year SRT was profitable.
SRT had a positive operating cash flow in the past year.
Each year in the past 5 years SRT has been profitable.
In the past 5 years SRT always reported a positive cash flow from operatings.
SRT.DE Yearly Net Income VS EBIT VS OCF VS FCFSRT.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

1.2 Ratios

Looking at the Return On Assets, with a value of 1.39%, SRT is doing worse than 78.95% of the companies in the same industry.
SRT has a worse Return On Equity (5.01%) than 68.42% of its industry peers.
SRT has a Return On Invested Capital of 4.71%. This is in the lower half of the industry: SRT underperforms 73.68% of its industry peers.
The Average Return On Invested Capital over the past 3 years for SRT is in line with the industry average of 9.25%.
Industry RankSector Rank
ROA 1.39%
ROE 5.01%
ROIC 4.71%
ROA(3y)4.22%
ROA(5y)4.59%
ROE(3y)15.69%
ROE(5y)18.55%
ROIC(3y)8.34%
ROIC(5y)10.45%
SRT.DE Yearly ROA, ROE, ROICSRT.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

1.3 Margins

With a Profit Margin value of 3.80%, SRT is not doing good in the industry: 78.95% of the companies in the same industry are doing better.
In the last couple of years the Profit Margin of SRT has declined.
SRT has a Operating Margin of 14.06%. This is in the lower half of the industry: SRT underperforms 68.42% of its industry peers.
SRT's Operating Margin has declined in the last couple of years.
The Gross Margin of SRT (46.48%) is better than 78.95% of its industry peers.
SRT's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 14.06%
PM (TTM) 3.8%
GM 46.48%
OM growth 3Y-21.14%
OM growth 5Y-7.77%
PM growth 3Y-35.47%
PM growth 5Y-21.95%
GM growth 3Y-5.43%
GM growth 5Y-2.63%
SRT.DE Yearly Profit, Operating, Gross MarginsSRT.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40 50

1

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so SRT is still creating some value.
SRT has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, SRT has more shares outstanding
SRT has a better debt/assets ratio than last year.
SRT.DE Yearly Shares OutstandingSRT.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
SRT.DE Yearly Total Debt VS Total AssetsSRT.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.2 Solvency

An Altman-Z score of 2.13 indicates that SRT is not a great score, but indicates only limited risk for bankruptcy at the moment.
With a Altman-Z score value of 2.13, SRT is not doing good in the industry: 63.16% of the companies in the same industry are doing better.
SRT has a debt to FCF ratio of 8.92. This is a slightly negative value and a sign of low solvency as SRT would need 8.92 years to pay back of all of its debts.
SRT has a Debt to FCF ratio of 8.92. This is in the lower half of the industry: SRT underperforms 68.42% of its industry peers.
A Debt/Equity ratio of 1.28 is on the high side and indicates that SRT has dependencies on debt financing.
SRT's Debt to Equity ratio of 1.28 is on the low side compared to the rest of the industry. SRT is outperformed by 78.95% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.28
Debt/FCF 8.92
Altman-Z 2.13
ROIC/WACC0.59
WACC7.94%
SRT.DE Yearly LT Debt VS Equity VS FCFSRT.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

2.3 Liquidity

SRT has a Current Ratio of 0.95. This is a bad value and indicates that SRT is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 0.95, SRT is doing worse than 84.21% of the companies in the same industry.
A Quick Ratio of 0.49 indicates that SRT may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.49, SRT is doing worse than 89.47% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.95
Quick Ratio 0.49
SRT.DE Yearly Current Assets VS Current LiabilitesSRT.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 59.34% over the past year.
Measured over the past years, SRT shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -11.87% on average per year.
Looking at the last year, SRT shows a small growth in Revenue. The Revenue has grown by 5.82% in the last year.
SRT shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 13.10% yearly.
EPS 1Y (TTM)59.34%
EPS 3Y-36.07%
EPS 5Y-11.87%
EPS Q2Q%24.14%
Revenue 1Y (TTM)5.82%
Revenue growth 3Y-0.67%
Revenue growth 5Y13.1%
Sales Q2Q%6.25%

3.2 Future

The Earnings Per Share is expected to grow by 19.29% on average over the next years. This is quite good.
Based on estimates for the next years, SRT will show a quite strong growth in Revenue. The Revenue will grow by 8.99% on average per year.
EPS Next Y22.69%
EPS Next 2Y21.53%
EPS Next 3Y21.2%
EPS Next 5Y19.29%
Revenue Next Year5.43%
Revenue Next 2Y6.87%
Revenue Next 3Y8.23%
Revenue Next 5Y8.99%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
SRT.DE Yearly Revenue VS EstimatesSRT.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2B 4B 6B
SRT.DE Yearly EPS VS EstimatesSRT.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2 4 6 8 10

2

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 42.72 indicates a quite expensive valuation of SRT.
73.68% of the companies in the same industry are cheaper than SRT, based on the Price/Earnings ratio.
Compared to an average S&P500 Price/Earnings ratio of 26.31, SRT is valued quite expensively.
The Price/Forward Earnings ratio is 32.18, which means the current valuation is very expensive for SRT.
Compared to the rest of the industry, the Price/Forward Earnings ratio of SRT indicates a slightly more expensive valuation: SRT is more expensive than 73.68% of the companies listed in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 36.56, SRT is valued at the same level.
Industry RankSector Rank
PE 42.72
Fwd PE 32.18
SRT.DE Price Earnings VS Forward Price EarningsSRT.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as SRT.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of SRT indicates a somewhat cheap valuation: SRT is cheaper than 68.42% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 30.48
EV/EBITDA 19.92
SRT.DE Per share dataSRT.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 -20 40

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates SRT does not grow enough to justify the current Price/Earnings ratio.
SRT's earnings are expected to grow with 21.20% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.88
PEG (5Y)N/A
EPS Next 2Y21.53%
EPS Next 3Y21.2%

4

5. Dividend

5.1 Amount

With a yearly dividend of 0.38%, SRT is not a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 0.70, SRT has a dividend in line with its industry peers.
With a Dividend Yield of 0.38, SRT pays less dividend than the S&P500 average, which is at 2.32.
Industry RankSector Rank
Dividend Yield 0.38%

5.2 History

The dividend of SRT has a limited annual growth rate of 3.71%.
Dividend Growth(5Y)3.71%
Div Incr Years3
Div Non Decr Years3
SRT.DE Yearly Dividends per shareSRT.DE Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 0.5 1

5.3 Sustainability

37.92% of the earnings are spent on dividend by SRT. This is a low number and sustainable payout ratio.
SRT's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP37.92%
EPS Next 2Y21.53%
EPS Next 3Y21.2%
SRT.DE Yearly Income VS Free CF VS DividendSRT.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M
SRT.DE Dividend Payout.SRT.DE Dividend Payout, showing the Payout Ratio.SRT.DE Dividend Payout.PayoutRetained Earnings

SARTORIUS AG

FRA:SRT (11/28/2025, 7:00:00 PM)

194.8

+3.6 (+1.88%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)10-16 2025-10-16/bmo
Earnings (Next)01-26 2026-01-26/bmo
Inst Owners4.37%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap14.59B
Revenue(TTM)3.52B
Net Income(TTM)133.70M
Analysts80
Price Target269.28 (38.23%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.38%
Yearly Dividend0.74
Dividend Growth(5Y)3.71%
DP37.92%
Div Incr Years3
Div Non Decr Years3
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-2.85%
Min EPS beat(2)-10.52%
Max EPS beat(2)4.83%
EPS beat(4)1
Avg EPS beat(4)-3.47%
Min EPS beat(4)-10.52%
Max EPS beat(4)4.83%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)0.05%
Min Revenue beat(2)-0.73%
Max Revenue beat(2)0.83%
Revenue beat(4)3
Avg Revenue beat(4)1.91%
Min Revenue beat(4)-0.73%
Max Revenue beat(4)4.87%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)4.45%
PT rev (3m)-1.12%
EPS NQ rev (1m)0%
EPS NQ rev (3m)3.45%
EPS NY rev (1m)-0.47%
EPS NY rev (3m)0.12%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)2.71%
Revenue NY rev (1m)0.28%
Revenue NY rev (3m)0.03%
Valuation
Industry RankSector Rank
PE 42.72
Fwd PE 32.18
P/S 4.15
P/FCF 30.48
P/OCF 16.68
P/B 5.47
P/tB N/A
EV/EBITDA 19.92
EPS(TTM)4.56
EY2.34%
EPS(NY)6.05
Fwd EY3.11%
FCF(TTM)6.39
FCFY3.28%
OCF(TTM)11.68
OCFY5.99%
SpS46.97
BVpS35.63
TBVpS-35.24
PEG (NY)1.88
PEG (5Y)N/A
Graham Number60.46
Profitability
Industry RankSector Rank
ROA 1.39%
ROE 5.01%
ROCE 6.33%
ROIC 4.71%
ROICexc 4.98%
ROICexgc 17.77%
OM 14.06%
PM (TTM) 3.8%
GM 46.48%
FCFM 13.61%
ROA(3y)4.22%
ROA(5y)4.59%
ROE(3y)15.69%
ROE(5y)18.55%
ROIC(3y)8.34%
ROIC(5y)10.45%
ROICexc(3y)8.77%
ROICexc(5y)11.17%
ROICexgc(3y)24.37%
ROICexgc(5y)31.52%
ROCE(3y)11.22%
ROCE(5y)14.06%
ROICexgc growth 3Y-35.26%
ROICexgc growth 5Y-11.95%
ROICexc growth 3Y-38.49%
ROICexc growth 5Y-19.53%
OM growth 3Y-21.14%
OM growth 5Y-7.77%
PM growth 3Y-35.47%
PM growth 5Y-21.95%
GM growth 3Y-5.43%
GM growth 5Y-2.63%
F-Score7
Asset Turnover0.37
Health
Industry RankSector Rank
Debt/Equity 1.28
Debt/FCF 8.92
Debt/EBITDA 3.69
Cap/Depr 92.32%
Cap/Sales 11.25%
Interest Coverage 2.65
Cash Conversion 94.72%
Profit Quality 357.97%
Current Ratio 0.95
Quick Ratio 0.49
Altman-Z 2.13
F-Score7
WACC7.94%
ROIC/WACC0.59
Cap/Depr(3y)148.03%
Cap/Depr(5y)150.65%
Cap/Sales(3y)13.71%
Cap/Sales(5y)12.64%
Profit Quality(3y)282.77%
Profit Quality(5y)224.27%
High Growth Momentum
Growth
EPS 1Y (TTM)59.34%
EPS 3Y-36.07%
EPS 5Y-11.87%
EPS Q2Q%24.14%
EPS Next Y22.69%
EPS Next 2Y21.53%
EPS Next 3Y21.2%
EPS Next 5Y19.29%
Revenue 1Y (TTM)5.82%
Revenue growth 3Y-0.67%
Revenue growth 5Y13.1%
Sales Q2Q%6.25%
Revenue Next Year5.43%
Revenue Next 2Y6.87%
Revenue Next 3Y8.23%
Revenue Next 5Y8.99%
EBIT growth 1Y18.65%
EBIT growth 3Y-21.66%
EBIT growth 5Y4.31%
EBIT Next Year99.69%
EBIT Next 3Y38.21%
EBIT Next 5Y26.81%
FCF growth 1Y123.33%
FCF growth 3Y7.25%
FCF growth 5Y29.73%
OCF growth 1Y6.61%
OCF growth 3Y4.07%
OCF growth 5Y20.79%

SARTORIUS AG / SRT.DE FAQ

What is the ChartMill fundamental rating of SARTORIUS AG (SRT.DE) stock?

ChartMill assigns a fundamental rating of 3 / 10 to SRT.DE.


Can you provide the valuation status for SARTORIUS AG?

ChartMill assigns a valuation rating of 2 / 10 to SARTORIUS AG (SRT.DE). This can be considered as Overvalued.


Can you provide the profitability details for SARTORIUS AG?

SARTORIUS AG (SRT.DE) has a profitability rating of 3 / 10.


What is the expected EPS growth for SARTORIUS AG (SRT.DE) stock?

The Earnings per Share (EPS) of SARTORIUS AG (SRT.DE) is expected to grow by 22.69% in the next year.


Can you provide the dividend sustainability for SRT stock?

The dividend rating of SARTORIUS AG (SRT.DE) is 4 / 10 and the dividend payout ratio is 37.92%.